YOLFTbeta
Oncosil Medical Ltd

Oncosil Medical Ltd

OSL · AU · Healthcare / Medical Devices

0.645AUD-0.01 (-0.77%)

Price History

Full chart

Market Stats

Previous Close0.65
Open0.66
Day Range0.645 – 0.665
52-Week Range0.37 – 1.81
Volume67.22K
Market Cap29.00M
P/E (TTM)0.00
Forward P/E4.51
EPS-0.48
Dividend Yield0.00%
Beta1.23
50-Day Avg1.08
200-Day Avg0.7918

About

OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Nigel Lange
  • Employees0
  • Headquarters7 Eden Park Drive, Macquarie Park, NSW, Australia, 2113, Australia
  • Websitehttps://www.oncosil.com

Leadership

  • Mr. Nigel LangeCEO, MD & Director
  • Ms. Shelley SteynChief Financial Officer
  • Mr. David TurnerHead of Medical Affairs
  • Prof. Jon BellChief Medical Officer
  • Mr. Henk TissingGlobal Head of Clinical Affairs
  • Mr. Renzo DiCarloHead of Transformation
  • Mr. Timothy Luscombe B.Com., C.A.Company Secretary
  • Ms. Nova Anne TaylorJoint Company Secretary

Financials

Income Statement

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-1.51M1.76M2.06M2.30M2.09M-164.00K88.00K315.86K2.76M3.84M3.51M4.45M3.63M2.76M213.07K231.79K367.68K516.63K1.17M1.68M
Growth (%)--+16.27%+17.41%+11.58%-9.37%---46.34%+258.93%+772.86%+39.17%-8.42%+26.58%-18.48%-23.77%-92.29%+8.79%+58.63%+40.51%+126.62%+43.92%
Cost of Revenue-556.92K960.39K1.09M1.46M1.34M-1712.20K2.98K6.71K21.36K29.13K39.91K38.62K149.29K961.02K972.47K1.59M1.51M2.25M7.88M
Gross Profit-954.91K797.98K978.12K843.64K749.88K---315.86K-6.71K3.82M3.48M4.41M3.59M2.62M-748.00K-6.73M-1.22M-993.00K-1.08M-6.20M
Gross Margin-63.16%45.39%47.39%36.63%35.93%---100.00%-0.24%99.45%99.17%99.10%98.92%94.61%-351.06%-2902.18%-332.08%-192.21%-92.49%-367.72%
Operating Expense-1.26M2.90M4.36M1.76M751.99K---4.48M2.89M12.69M14.29M17.50M16.00M9.82M10.88M4.68M11.33M12.04M14.41M8.22M
Operating Income-33.98K-307.00K-2.10M-3.38M-915.00K-2.11K-504.11K-415.00K-882.00K-4.16M-2.90M-8.87M-10.81M-13.09M-12.41M-7.21M-11.63M-11.41M-12.55M-13.03M-15.49M-14.42M
Operating Margin--20.30%-119.51%-163.66%-39.73%-0.10%--253.05%-1002.27%-1318.00%-105.22%-231.25%-307.63%-294.27%-342.31%-260.85%-5456.96%-4922.29%-3414.28%-2522.68%-1322.94%-855.64%
EBITDA-26.34K-282.00K-2.00M-3.09M-582.00K59.20K-504.11K-431.00K-877.00K-4.16M-2.90M-8.58M-10.43M-12.94M-12.15M-4.11M-11.31M-11.41M-11.17M-12.91M-15.06M-14.36M
EBITDA Margin--18.65%-113.65%-149.90%-25.27%2.84%--262.80%-996.59%-1317.05%-105.01%-223.61%-296.90%-290.94%-335.19%-148.77%-5308.21%-4922.15%-3037.18%-2499.74%-1286.60%-852.10%
Net Income-26.42K-128.00K-1.67M-2.77M-440.00K-1.71M-1.46M-431.00K-879.00K-6.87M-2.88M-4.77M-7.02M-8.54M-8.57M-4.26M-10.43M-10.73M-11.34M-11.91M-15.10M-10.86M
Net Income Margin--8.47%-95.22%-134.06%-19.11%-82.03%--262.80%-998.86%-2173.45%-104.43%-124.29%-199.66%-192.00%-236.27%-154.20%-4896.98%-4627.92%-3085.04%-2306.09%-1289.71%-644.53%
R&D-491.07K1.79M2.77M247.38K67.92K--129.66K947.62K1.74M3.34M3.96M5.78M5.58M3.73M2.89M2.38M2.85M2.99M4.21M5.47M
R&D as % of Total Revenue-32.48%101.71%134.45%10.74%3.25%--147.35%300.02%63.18%87.07%112.58%129.97%153.78%134.80%1355.42%1025.07%775.41%578.75%359.66%324.77%
Interest Expense00000000000000011.09K15.75K19.62K10.90K3.94K72216.80K
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%-0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.40%7.39%8.47%2.96%0.76%0.06%1.00%

Balance Sheet

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets946.59K8.18M7.00M6.17M5.23M2.96M3.03M2.52M6.24M9.64M7.41M15.90M11.80M19.88M11.67M24.06M14.15M13.07M11.47M6.72M7.15M10.31M
Total Liabilities47.03K2.73M2.32M2.08M945.93K380.95K116.89K40.79K192.95K120.72K445.70K1.09M1.67M1.73M993.21K2.16M2.45M1.91M1.59M1.98M4.04M5.31M
Total Equity899.56K5.46M4.68M4.09M4.28M2.58M2.91M2.48M6.05M9.51M6.96M14.81M10.13M18.15M10.68M21.90M11.70M11.16M9.88M4.74M3.10M5.00M
Cash887.48K2.82M1.90M1.75M1.40M1.55M2.73M2.41M3.51M2.74M2.52M9.78M8.00M15.21M7.69M21.00M12.24M11.28M9.39M4.50M5.11M6.48M
Total Debt-617.44K367.56K148.86K----------109.94K109.94K484.37K304.21K170.81K70.67K69.92K14.78K
Net Debt-887.48K-2.20M-1.53M-1.60M-1.40M-1.55M-2.73M-2.41M-3.51M-2.74M-2.52M-9.78M-8.00M-15.21M-7.69M-20.89M-11.76M-10.98M-9.22M-4.43M-5.04M-6.46M

Cash Flow

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-18.08K195.51K-1.35M-2.18M-103.97K154.35K-316.67K-305.78K-471.91K-6.37M-171.16K-4.57M-6.11M-8.40M-7.50M-4.46M-8.82M-10.11M-11.32M-10.82M-12.06M-10.47M
Investing Cash Flow-14.08K-131.58K-241.89K-35.23K-67.34K40.42K-277.70K-10.64K-74.00K-4.30M-45.21K-57.98K3.38M-10.70K-14.83K-20.72K-54.00K-5.83K-57.82K-197.06K-14.96K-1.46K
Financing Cash Flow919.64K1.86M671.82K2.08M-155.56K-1.77M6001.65M9.90M11.89M11.89M950.00K15.61M17.79M17.79M111.25K9.16M9.49M6.13M12.73M11.86M
Capital Expenditure2.75K271.11K241.89K35.23K67.34K30.48K3.08K2.40K101.45K15.82K45.21K57.98K52.89K10.70K14.83K20.72K54.00K5.83K57.82K197.06K14.96K1.45K
Free Cash Flow-20.83K-75.59K-1.59M-2.22M-171.32K123.87K-316.67K-308.18K-573.36K-6.39M-216.37K-4.63M-6.16M-8.41M-7.52M-4.48M-8.87M-10.12M-11.37M-11.02M-12.08M-10.47M
Dividends Paid---------------16.69M------
FCF to OCF115.20%-38.67%117.98%101.62%164.77%80.25%100.00%100.78%121.50%100.25%126.42%101.27%100.87%100.13%100.20%100.47%100.61%100.06%100.51%101.82%100.12%100.01%
Dividend Paid to FCF----------------372.74%------

Earnings

Report DateFeb 15, 2016Aug 30, 2016Feb 23, 2017Aug 24, 2017Feb 20, 2018Aug 22, 2018Feb 19, 2019Aug 22, 2019Feb 26, 2020Aug 19, 2020Feb 22, 2021Aug 18, 2021Feb 22, 2022Aug 30, 2022Feb 28, 2023Feb 25, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.000.00
EPS Actual0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.010.00-0.01-0.01-0.01-0.01-0.01-0.68-0.70
Surprise-----------------
TimingPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-After-hours---

Key Statistics & Ratios

Market Cap29.00M
Enterprise Value23.82M
Trailing P/E0.00
Forward P/E4.51
Price / Sales5.70
Price / Book6.06
EPS-0.48
Book Value0.162
Revenue (TTM)5.09M
Gross Profit (TTM)2.73M
EBITDA-11.00M
Profit Margin-213.40%
Operating Margin-336.60%
Return on Equity-268.16%
Return on Assets-78.85%
Shares Outstanding36.70M
Shares Float24.43M
Beta1.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 5, 20261226:1219
  • Jun 3, 20251:400
  • Mar 27, 202418:17
  • Mar 22, 202316:13
  • May 5, 2022165:163
  • May 6, 2020564:553
  • Sep 3, 2010108:97